Radiation dose to patients and relatives incident to 131I therapy

Thyroid

Volumn 7, Issue 2, 1997, Pages 199-204

  Zanzonico, Pat B ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

CANCER RISK; HUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION HAZARD; REVIEW; THYROID DISEASE;

EID: 0030931203     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.199     Document Type: Review

References (20)

1. Berman M, Hoff E, Barandes M, et al. 1968 Iodine kinetics in man: A model. J Clin Endocrinol 28:1-14.
2. Nishizawa K, Ohara K, Ohshima M, et al. 1980 Monitoring of excretions and used materials of patients treated with 1131. Health Physics 38:467-481.
3. Pochin EE, Kermode JC 1975 Protection problems in radionuclide therapy: The patient as a gamma radiation source. Br J Radiol 48:299-305.
4. Edmonds CJ, Smith T 1986 The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 59:45-51.
5. Zanzonico PB, Backer DV, Brill AB, et al. 1989 Extra-thyroidal absorbed doses in radioiodine treatment of hyperthyroidism: Compartmental modeling-based analysis of 468 patients. J Nucl Med 30:833 (abstract).
6. Barandes M, Hurley HR, Becker DV 1973 Implications of rapid thyroidal iodine turnover for 1131 therapy: The small pool syndrome. J Nucl Med 14:379 (abstract).
7. Becker DV, Zanzonico PB, Hurley JR, et al. 1991 Treatment of hyperthyroidism with 131-1: Continuation of antithyroid drugs does not adversely affect therapy and in "small pool" patients reduces the extrathyroidal radiation dose. In: Gordon A, Gross J, Henneman G (eds) Progress in thyroid research. Balkema, Rotterdam, pp. 223-226.
8. Zanzonico PB, Becker DV, Hurley JR, et al. 1991 Enhancement of radioiodine therapy of hyperthyroidism in "small pool" patients: Dosimetric methodology and results. J Nucl Med 32:1017 (abstract).
9. Zanzonico PB, Becker DV 1991 Radiation hazards in children born to mothers exposed to 131-iodine. In: Beckers C, Reinwein D (eds) The thyroid and pregnancy. Schattauer, Stuttgart, pp. 189-202.
10. Killough GG, Eckerman KF 1986 Age- and sex-specific estimation of dose to normal thyroid from clinical administration of iodine-131. NUREG/CR-3955, ORNL/TM-9800. Oak Ridge National Laboratory, Oak Ridge, Tennessee p. 12.
11. Culver CM, Dworkin HJ 1991 Radiation safety considerations for post-iodine-131 hyperthyroid therapy. J Nucl Med 32:169-173.
12. O'Doherty MJ, Kettle AG, Eustance CNP, et al. 1993 Radiation dose rates from adult patients receiving 1131 therapy for thyrotoxicosis. Nucl Med Com 14:160-168.
13. Castronovo FP Jr, Beh RA, Veilleux NM 1982 Dosimetric considerations while attending hospitalized I-131 therapy patients. J Nucl Med Tech 10:157-160.
14. Culver CM, Dworkin HJ 1992 Radiation safety considerations for post-iodine-131 thyroid cancer therapy. J Nucl Med 33:1402-1405.
15. National Council on Radiation Protection and Measurements 1996 Source and magnitude of occupational and public exposures from nuclear medicine procedures. NCRP Report no. 124. NCRP, Bethesda, Maryland.
16. National Council on Radiation Protection and Measurements 1993 Limitation of exposure to ionizing radiation. NCRP Report no. 116. NCRP, Bethesda, Maryland.
17. Buchan RCT, Brindle JM 1970 Radioiodine therapy to outpatients: The contamination hazard. Br J Radiol 43:479-482.
18. Buchan RCT, Brindle JM 1971 Radioiodine therapy to outpatients: The radiation hazard. Br J Radiol 44:973-975.
19. Harbert JC, Wells N 1974 Radiation exposure of the family of radioactive patients. J Nucl Med 15:887-888.
20. Jacobsen AP, Plato PA, Toeroek D 1978 Contamination of the home environment by patients treated with iodine-131: Initial results. Am J Publ Health 68:228-230.